ProShares UltraShort Profile

16.95
USD 0.26  1.56%
7%
59%

ProShares UltraShort Summary

ProShares UltraShort Nasdaq Biotech [BIS] is traded in USA and was established on July 16, 2018. The fund is classified under Sector category within ProShares family. ProShares UltraShort Nasdaq Biotech currently have 25.62 M in assets under management (AUM). , while the total return for the last 3 years was -14.91%.
Check ProShares UltraShort Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

Target Price Odds Analysis

Odds Below 16.95HorizonTargetOdds Above 16.95
8.33%30 days 16.95 91.59%
Based on normal probability distribution, the odds of ProShares UltraShort to move above current price in 30 days from now is about 91.59% (This ProShares UltraShort Nasdaq Biotech probability density function shows the probability of ProShares UltraShort Etf to fall within a particular range of prices over 30 days) .

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Healthcare Value Capital LlcFund Units75 K1.6 M
Healthcare Value Capital LlcCall Options50 K1.1 M
Jane Street Group LlcPut Options18.5 K408 K
View ProShares UltraShort Diagnostics

ProShares UltraShort Risk Profiles

ProShares UltraShort Technical Analysis

Transformation
Array is null. The output start index for this execution was zero with a total number of output elements of zero. ProShares UltraShort Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe ProShares UltraShort price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Key Fundamentals

ProShares UltraShort Against Markets

Current Ratings

ProShares UltraShort 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
52 
Equity ratings for ProShares UltraShort Nasdaq Biotech are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks daily investment results that correspond to two times the inverse of the daily performance of the Nasdaq Biotechnology Index. ProShares UltraShort is traded on NASDAQ General Markets in USA. more
NameProShares UltraShort Nasdaq Biotech
CEOMukhtar KalyanView All
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerProShares
ExchangeNASDAQ General Markets
Etf FamilyProShares
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone866 776 5125
CurrencyUSD - US Dollar
IssuerProShares
DescriptionProShares UltraShort Nasdaq Biotechnology
Inception Date2010-04-07
BenchmarkNASDAQ Biotechnology TR USD
Entity TypeRegulated Investment Company
Asset Under Management25.62 Million
Average Trading Valume32,744
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Portfolio ManagerMichael Neches, Tarak Dave
Transfer AgentJPMorgan Chase Bank, N.A.
Fiscal Year EndMay 31
ExchangeThe NASDAQ Stock Market LLC
Market MakerVirtu Financial
Total Expense1.11
Management Fee0.75

Did you try this?

Run Price Transformation Now
   

Price Transformation

Use Price Transformation models to analyze depth of different equity instruments across global markets
All  Next Launch Price Transformation
Check also Trending Equities. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.